BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11250988)

  • 21. Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy.
    Noy A; Yahalom J; Zaretsky L; Brett I; Zelenetz AD
    J Clin Oncol; 2005 Jun; 23(16):3768-72. PubMed ID: 15923573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.
    Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F
    Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection.
    Morgner A; Lehn N; Andersen LP; Thiede C; Bennedsen M; Trebesius K; Neubauer B; Neubauer A; Stolte M; Bayerdörffer E
    Gastroenterology; 2000 May; 118(5):821-8. PubMed ID: 10784580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
    J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
    Bayerdörffer E; Neubauer A; Rudolph B; Thiede C; Lehn N; Eidt S; Stolte M
    Lancet; 1995 Jun; 345(8965):1591-4. PubMed ID: 7783535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.
    Wündisch T; Dieckhoff P; Greene B; Thiede C; Wilhelm C; Stolte M; Neubauer A
    Gastroenterology; 2012 Oct; 143(4):936-42; quiz e13-4. PubMed ID: 22750463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study.
    Montalban C; Santón A; Redondo C; García-Cosio M; Boixeda D; Vazquez-Sequeiros E; Norman F; de Argila CM; Alvarez I; Abraira V; Bellas C
    Ann Oncol; 2005 Sep; 16(9):1539-44. PubMed ID: 15946976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy.
    Savio A; Zamboni G; Capelli P; Negrini R; Santandrea G; Scarpa A; Fuini A; Pasini F; Ambrosetti A; Paterlini A; Buffoli F; Angelini GP; Cesari P; Rolfi F; Graffeo M; Pascarella A; Valli M; Mombello A; Ederle A; Franzin G
    Recent Results Cancer Res; 2000; 156():116-24. PubMed ID: 10802871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis.
    Nakamura S; Aoyagi K; Furuse M; Suekane H; Matsumoto T; Yao T; Sakai Y; Fuchigami T; Yamamoto I; Tsuneyoshi M; Fujishima M
    Am J Pathol; 1998 May; 152(5):1271-9. PubMed ID: 9588895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: clinicopathologic analysis of 19 cases.
    Chiang IP; Wang HH; Cheng AL; Lin JT; Su IJ
    J Formos Med Assoc; 1996 Nov; 95(11):857-65. PubMed ID: 8990774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of B-cell monoclonality in follicular gastritis: a possible association between follicular gastritis and MALT lymphoma.
    Miyamoto M; Haruma K; Hiyama T; Kamada T; Masuda H; Shimamoto F; Inoue K; Chayama K
    Virchows Arch; 2002 Apr; 440(4):376-80. PubMed ID: 11956817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
    Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH
    Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Frutos B; Calleja JL; Sánchez-Godoy P; Bellas C
    Med Clin (Barc); 1998 Jan; 110(2):41-4. PubMed ID: 9534129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
    Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
    Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial.
    Bertoni F; Conconi A; Capella C; Motta T; Giardini R; Ponzoni M; Pedrinis E; Novero D; Rinaldi P; Cazzaniga G; Biondi A; Wotherspoon A; Hancock BW; Smith P; Souhami R; Cotter FE; Cavalli F; Zucca E; ;
    Blood; 2002 Apr; 99(7):2541-4. PubMed ID: 11895791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonality analyses in gastric MALT (mucosa-associated lymphoid tissue).
    Steiff JN; Neubauer A; Stolte M; Wündisch T
    Pathol Res Pract; 2006; 202(7):503-7. PubMed ID: 16687216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.